RACCNasdaqPharmaceutical PreparationsFiscal year ends December 31
Research Alliance Corp III
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 12, 2026
$10.23+0.07 (+0.69%)
Close on Oct 19, 2026
- Market cap
- –
- P/E (TTM)
- –
- Dividend yield
- –
Research Alliance Corp III statistics
Financials through Jun 30, 2026, price as of Oct 19, 2026, median of Pharmaceutical Preparations companies for comparison
Valuation
| Measure | Research Alliance Corp III | Industry median |
|---|---|---|
| Market Cap | $93.08M | $166.30M |
| Enterprise Value | $92.25M | $88.19M |
Balance sheet
| Measure | Research Alliance Corp III | Industry median |
|---|---|---|
| Cash & Short-Term Investments | $832.81K | $61.43M |
| Net Cash (Debt) | $832.81K | $15.35M |
| Net Cash Per Share | $0.09 | $0.66 |
| Equity (Book Value) | -$1.24M | $49.09M |
| Book Value Per Share | -$0.14 | $1.37 |
| Tangible Book Value | -$1.24M | $23.52M |
| Working Capital | $905.87K | $76.81M |
Financial position
| Measure | Research Alliance Corp III | Industry median |
|---|---|---|
| Current Ratio | 17.30 | 3.34 |
| Quick Ratio | 14.98 | 2.44 |
Shares
| Measure | Research Alliance Corp III | Industry median |
|---|---|---|
| Shares Outstanding | 9,098,530 | 58,127,000 |
| Float | 7,303,260 | 49,136,700 |
| Shares Held by Insiders | 19.7% | 11.6% |
Scores
| Measure | Research Alliance Corp III | Industry median |
|---|---|---|
| Altman Z-Score | 24.21 | -0.22 |
Calculated by StockData from Research Alliance Corp III's SEC filings and the latest closing price. Hover a measure to see its formula. The grey column is the median of companies in the same industry group (two-digit SIC code); green or red marks a better or worse value than that median.